Back to search
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Metastatic Non-small Cell Lung Cancer With MTAP Deletion trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Metastatic Non-small Cell Lung Cancer With MTAP Deletion trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of this study is to compare the clinical benefit of the combination of Navlimetostat (BMS-986504) (a selective MTA-cooperative inhibitor of PRMT5) p…
This is a multicenter clinical study to evaluate the safety, efficacy, and Pharmacokinetics (PK) of IDE892 as monotherapy and in combination with other agents i…
The purpose of this study is to evaluate the safety and efficacy of Navlimetostat (BMS-986504) monotherapy in participants with advanced or metastatic Non-small…
TNG462-C102 is a Phase 1/2, open-label, multicenter study designed to determine the safety, tolerability, PK, PD, and preliminary antineoplastic activity of ora…